{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T16:34:30Z","timestamp":1793637270565,"version":"4.5.1"},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32100739"],"award-info":[{"award-number":["32100739"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.euroneuro.2025.01.002","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T02:07:31Z","timestamp":1738116451000},"page":"19-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Disease continuum centered on Parkinson's disease"],"prefix":"10.1016","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3651-7701","authenticated-orcid":false,"given":"Ming","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2025.01.002_bib0001","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/mds.28104","article-title":"Outcome of Parkinson's disease patients affected by COVID-19","volume":"35","author":"Antonini","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.euroneuro.2025.01.002_bib0002","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1002\/mds.29122","article-title":"The impact of type 2 diabetes in Parkinson's disease","volume":"37","author":"Athauda","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.euroneuro.2025.01.002_bib0003","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.abb8587","article-title":"Microglia modulate neurodegeneration in Alzheimer's and Parkinson's diseases","volume":"370","author":"Bartels","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.euroneuro.2025.01.002_bib0004","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/mds.28622","article-title":"Parkinson's disease and Post-COVID-19 syndrome: the Parkinson's long-COVID spectrum","volume":"36","author":"Leta","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.euroneuro.2025.01.002_bib0005","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41582-020-0344-4","article-title":"Parkinson disease and the immune system - associations, mechanisms and therapeutics","volume":"16","author":"Tan","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.euroneuro.2025.01.002_bib0006","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.euroneuro.2024.12.009","article-title":"Disease-wide association study uncovers disease continuum network of unipolar depression","volume":"92","author":"Zheng","year":"2025","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2025.01.002_bib0007","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pcad.2024.09.005","article-title":"Landscape of stroke comorbidities: a disease-wide association study","volume":"86","author":"Zheng","year":"2024","journal-title":"Prog. Cardiovasc. Dis."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X25000021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X25000021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T07:11:26Z","timestamp":1744269086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X25000021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":7,"alternative-id":["S0924977X25000021"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2025.01.002","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disease continuum centered on Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2025.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. and ECNP. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}